Loni da Silva MS RAC has a strong background in regulatory affairs, with over 30 years of experience in the pharmaceutical industry. Loni currently holds the position of Chief Regulatory Officer at EyeBio since 2023. Prior to joining EyeBio, Loni served as the President of Creative Regulatory Consulting LLC, a company they founded in 2004.
Loni has also held various leadership roles at Oyster Point Pharma, including Senior Vice President of Regulatory Affairs from 2021 to 2023, and Vice President and Head of Regulatory Affairs from 2018 to 2023.
Before their time at Oyster Point Pharma, Loni was the SVP of Global Regulatory Affairs at Ophthotech Corp from 2007 to 2017, and the VP of Global Regulatory Affairs at Pharmasset, Inc. from 2005 to 2007.
Loni began their career at Eyetech Pharmaceuticals as the Vice President of Regulatory Affairs from 2000 to 2005, and prior to that, they served as the Senior Director of Regulatory Affairs at Hoffman La-Roche from 1987 to 2000.
Throughout their career, Loni has demonstrated expertise in regulatory affairs and has played a key role in ensuring compliance with regulatory requirements in the pharmaceutical industry.
Loni da Silva MS RAC has a Bachelor of Science degree in Microbiology from Penn State University, which was obtained from 1981 to 1985. Afterward, they pursued higher education and earned a Master of Science degree in Regulatory Affairs from Long Island University between 1993 and 1995. Additionally, Loni holds the RAC certification from the Regulatory Affairs Professionals Society (RAPS). There is no specified information regarding the month or year they obtained this certification.
Sign up to view 0 direct reports
Get started